Triton X

Triton X

SCHEMBL33822

CC(C)(C)CC(C)(C)c1ccc(OCCO)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
SHBG P04278 1/20 0.53
HIF1A Q16665 4/20 0.49
ALDH1A1 P00352 3/20 0.49
USP2 O75604 3/20 0.49
LMNA P02545 3/20 0.49
MEN1 O00255 2/20 0.49
APAF1 O14727 2/20 0.49
ERBB2 P04626 2/20 0.49
TP53 P04637 2/20 0.49
FYN P06241 2/20 0.49
CHRM2 P08172 2/20 0.49
CHRM4 P08173 2/20 0.49
CHRM5 P08912 2/20 0.49
ADRA2A P08913 2/20 0.49
MAPT P10636 2/20 0.49
HSPD1 P10809 2/20 0.49
CHRM1 P11229 2/20 0.49
TSHR P16473 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triton X SCHEMBL21176032 1.00 CYP3A4 (1.00) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
Triton X SCHEMBL15135853 0.97 CYP3A4 (0.93) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
Triton X SCHEMBL5933893 0.97 CYP3A4 (0.93) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL2108029 0.91 CYP3A4 (0.84) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL20168125 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL16198907 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL1091879 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL2961794 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL13932430 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1
SCHEMBL28476646 0.90 CYP3A4 (0.82) CYP3A4SMN1; SMN2SHBGHIF1AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6331 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122084607-A Method for monitoring coagulation activity and corresponding system 2026-05-26 CN claimed
US-20260137829-A1 METHOD FOR DYEING SUTURE MATERIAL CORZA MEDICAL INC (US) 2026-05-21 US claimed
US-20260126674-A1 ELECTRO-OPTO-ACOUSTIC COMPOSITION AND ELECTRO-OPTO-ACOUSTIC DEVICE KOREA UNIVERSITY OF TECHNOLOGY AND EDUCATION INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2026-05-07 US claimed
US-20260115155-A1 STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN CHORDA PHARMA INC (US) 2026-04-30 US claimed
EP-4729586-A1 INK COMPOSITION USING NANO COPPER COMPOUND HAVING HIGH NEAR-INFRARED ABSORBENCY Nano CMS Co., Ltd. (KR) 2026-04-22 EP claimed
EP-4414063-B1 NANONETS FOR REMOVAL OF CONTAMINANTS FROM AQUEOUS SOLUTIONS, KITS THEREFOR AND METHODS OF THEIR USE CARBONET NANOTECHNOLOGIES INC (CA) 2026-04-15 EP claimed
EP-4720673-A2 EPIGENOMIC ANALYSIS OF FORMALIN-FIXED PARAFFIN-EMBEDDED SAMPLES Fred Hutchinson Cancer Center (US) 2026-04-08 EP claimed
EP-4719350-A1 STABLE CYCLOSPORINE OPHTHALMIC FORMULATION AND MANUFACTURING PROCESS THEREOF Sun Pharmaceutical Industries Limited (IN) 2026-04-08 EP claimed
US-20260085367-A1 LAMP ASSAY SYSTEM FOR DETECTION OF RESPIRATORY VIRUS DELTA ELECTRONICS INT’L SINGAPORE PTE LTD (SG) 2026-03-26 US claimed
EP-4713468-A1 AN ENZYMATIC PROCESS FOR THE PRODUCTION OF VERBENONE AND IMPLEMENTATIONS THEREOF ATGC Biotech Pvt Ltd (IN) 2026-03-25 EP claimed
EP-1242576-B1 STABILIZING DILUENT FOR POLYPEPTIDES AND ANTIGENS THERMO BIOSTAR INC (US) 2005-04-13 EP claimed
US-6863866-B2 Self-contained devices for detecting biological contaminants BIOCONTROL SYSTEMS, INC. (US) 2005-03-08 US claimed
US-20040126513-A1 Absorbent pad with controlled rate of wicking NOVIPAX LLC 2004-07-01 US claimed
US-20040025732-A1 Field electron emission materials and devices PRINTABLE FIELD EMITTERS LIMITED (GB) 2004-02-12 US claimed
US-6579688-B2 Stabilizing diluent for polypeptides and antigens BIOSTAR, INC. 2003-06-17 US claimed
US-6174503-B1 NUCLEAR WASTES TREATMENT, ESPECIALLY WASTES WITH A HIGH CONCENTRATION OF COMPETING ALKALI METAL CATIONS LOCKHEED MARTIN ENERGY RESEARCH CORPORATION 2001-01-16 US claimed
EP-0900286-A1 HIGH VOLUME IN-SITU mRNA HYBRIDIZATION METHOD FOR THE QUANTIFICATION AND DISCOVERY OF DISEASE SPECIFIC GENES PHARMACIA & UPJOHN COMPANY (US) 1999-03-10 EP claimed
WO-1997040189-A1 HIGH VOLUME IN-SITU mRNA HYBRIDIZATION METHOD FOR THE QUANTIFICATION AND DISCOVERY OF DISEASE SPECIFIC GENES PHARMACIA & UPJOHN COMPANY (US) 1997-10-30 WO claimed
US-5312628-A Isolation of a soluble 42 KD pancreatic islet cell autoantigen EXOCELL, INC. (US) 1994-05-17 US claimed
US-4143080-A WATER SOLUBLE IODIDE, REDOX CATALYST, STABILIZER IN SPECIFIC CONCENTRATIONS FOR PHOTOMETRIC DETERMINATIONS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1979-03-06 US claimed